Evidence map›Paper›PMID 38062245›Full record

ArticleCell death and differentiation2024

SALL4 is a CRL3

Ludovica Lospinoso Severini, Elena Loricchio, Shirin Navacci, Irene Basili, Romina Alfonsi, Flavia Bernardi, Marta Moretti, Marilisa Conenna, Antonino Cucinotta, Sonia Coni and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Cell death and differentiation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Transcranial photobiomodulation ameliorates midbrain and striatum neurochemical impairments and behavioral deficits in reserpine-induced parkinsonism in rats.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 2 countries.

Ludovica Lospinoso Severini *Department of Molecular Medicine, University of Rome La Sapienza, 00161, Rome, Italy.
Elena Loricchio *Department of Molecular Medicine, University of Rome La Sapienza, 00161, Rome, Italy.
Shirin Navacci *Department of Molecular Medicine, University of Rome La Sapienza, 00161, Rome, Italy.
Irene BasiliDepartment of Molecular Medicine, University of Rome La Sapienza, 00161, Rome, Italy.
Romina AlfonsiCentro Nazionale per il Controllo e la Valutazione dei Farmaci, Istituto Superiore di Sanità, 00161, Rome, Italy.ORCID 0000-0001-5100-5491
Flavia BernardiInstitut Curie, PSL Research University, CNRS UMR, INSERM, 91401, Orsay, France.
Marta MorettiDepartment of Experimental Medicine, University of Rome La Sapienza, 00161, Rome, Italy.ORCID 0000-0003-4705-6442
Marilisa ConennaDepartment of Molecular Medicine, University of Rome La Sapienza, 00161, Rome, Italy.
Antonino CucinottaDepartment of Molecular Medicine, University of Rome La Sapienza, 00161, Rome, Italy.
Sonia ConiDepartment of Molecular Medicine, University of Rome La Sapienza, 00161, Rome, Italy.
Marialaura PetroniDepartment of Molecular Medicine, University of Rome La Sapienza, 00161, Rome, Italy.
Enrico De SmaeleDepartment of Experimental Medicine, University of Rome La Sapienza, 00161, Rome, Italy.ORCID 0000-0003-4524-4423
Giuseppe GianniniDepartment of Molecular Medicine, University of Rome La Sapienza, 00161, Rome, Italy.ORCID 0000-0003-0299-4056
Marella MaroderDepartment of Molecular Medicine, University of Rome La Sapienza, 00161, Rome, Italy.ORCID 0000-0001-5151-435X
Gianluca CanettieriDepartment of Molecular Medicine, University of Rome La Sapienza, 00161, Rome, Italy.ORCID 0000-0001-6694-2613
Angela MastronuzziDepartment of Pediatric Haematology and Oncology, and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, 00165, Rome, Italy.ORCID 0000-0002-4408-2373
Daniele GuardavaccaroDepartment of Biotechnology, University of Verona, 37134, Verona, Italy.ORCID 0000-0002-4517-1765
Olivier AyraultInstitut Curie, PSL Research University, CNRS UMR, INSERM, 91401, Orsay, France.
Paola InfanteDepartment of Molecular Medicine, University of Rome La Sapienza, 00161, Rome, Italy.
Francesca BufalieriDepartment of Molecular Medicine, University of Rome La Sapienza, 00161, Rome, Italy. francesca.bufalieri@uniroma1.it.ORCID 0000-0002-9571-318X
Lucia Di MarcotullioDepartment of Molecular Medicine, University of Rome La Sapienza, 00161, Rome, Italy. lucia.dimarcotullio@uniroma1.it.ORCID 0000-0003-0274-7178
Sapienza University of Rome · ITIstituto Pasteur · ITUniversité Paris-Sud · FRBambino Gesù Children's Hospital · ITCentre National de la Recherche Scientifique · FRIstituto Superiore di Sanità · ITUniversity of Verona · IT

Funding

Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) FIRC-AIRC FellowshipAssociazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) IG20801Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) IG24329Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) IG25833Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) MFAG 2021-ID. 26536Ministero della Salute (Ministry of Health, Italy) Dipartimenti di Eccellenza (2023-2027)Ministero della Salute (Ministry of Health, Italy) Dipartimenti di Eccellenza - L. 232/2016Ministero della Salute (Ministry of Health, Italy) PRIN2017BF3PXZ
6 · The paper itself

Abstract

The Sonic Hedgehog (SHH) pathway is crucial regulator of embryonic development and stemness. Its alteration leads to medulloblastoma (MB), the most common malignant pediatric brain tumor. The SHH-MB subgroup is the best genetically characterized, however the molecular mechanisms responsible for its pathogenesis are not fully understood and therapeutic benefits are still limited. Here, we show that the pro-oncogenic stemness regulator Spalt-like transcriptional factor 4 (SALL4) is re-expressed in mouse SHH-MB models, and its high levels correlate with worse overall survival in SHH-MB patients. Proteomic analysis revealed that SALL4 interacts with REN/KCTD11 (here REN), a substrate receptor subunit of the Cullin3-RING ubiquitin ligase complex (CRL3

Indexed as

Brain NeoplasmsCerebellar NeoplasmsMedulloblastomaAnimalsCell Cycle ProteinsDNA-Binding ProteinsHedgehog ProteinsHumansMiceProteomicsTranscription FactorsTransferasesZinc Finger Protein GLI1Cell Cycle ProteinsDNA-Binding ProteinsHedgehog ProteinsKCTD11 protein, humanKctd11 protein, mouseSALL4 protein, humanSall4 protein, mouseSHH protein, humanShh protein, mouseTranscription FactorsTransferasesZinc Finger Protein GLI1

Identifiers

PMID38062245
PMCPMC10850099
OpenAlexW4389455285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.